SII asked to submit approvals from DSMB India & UK to resume vax trial
New Delhi, Sep 12 (SocialNews.XYZ) The Drug Controller General of India (DCGI) has directed the Serum Institute of India (SII) to submit approvals from Data Safety Monitoring Boards (DSMB) of India and the UK to…



















